Superoxide dismutase mimic
First Claim
Patent Images
1. A low molecular weight mimic of superoxide dismutase activity comprising a water solube complex formed between a chelating agent and manganese, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of forming said complex.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a water-soluble complex formed between a chelating agent and manganese and pharmaceutical compositions thereof. The complex is a low molecular weight mimic of superoxide dismutase. The invention further relates to a method of using the complex comprising treating plant and animal cells with an amount of the complex sufficient to reduce or prevent superoxide radical-induced toxicity.
64 Citations
48 Claims
- 1. A low molecular weight mimic of superoxide dismutase activity comprising a water solube complex formed between a chelating agent and manganese, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of forming said complex.
- 5. A pharmaceutical composition comprising, as an active ingredient, a water-soluble complex formed between a chelating agent and manganese, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of forming said complex, which complex is present in an amount sufficient to reduce or prevent superoxide radical-induced toxicity, together with a pharmaceutically acceptable carrier.
-
10. A low molecular mimic of superoxide dismutase produced by a method comprising the steps of:
-
a) combining a manganese (IV) salt with a chelating agent in water or an aqueous buffer, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of complexing with manganese; b) stirring said combination until reaction between said chelating agent and manganese is complete; and c) removing residual manganese salt from a resulting solution. - View Dependent Claims (11, 18)
-
-
12. A low molecular weight mimic of superoxide dismutase activity produced by a method comprising the steps of:
-
a) combinting a manganese(II) salt with a chelating agent in a neutral oxygenated aqueous solution, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of complexing with manganese; b) stirring said combination until reaction between said chelating agent and manganese is complete; and c) removing any residual manganese salt from a resulting solution.
-
-
13. A mimic of superoxide dismutase activity produced by a method comprising the steps of:
-
a) combing a manganese salt, in which salt manganese has a valence of III, V, VI or VII, with a chelating agent under such conditions that manganese achieves an actual valence of three, wherein said chelating agent is a hydroxamate-type siderophore, or analog or derivative thereof capable of complexing with manganese; b) stirring said combination until reaction between said chelating agent and said manganese is complete; and c) removing any residual manganese salt from a resulting solution. - View Dependent Claims (36)
-
-
14. A low molecular weight mimic of superoxide dismutase activity produced by a method comprising the steps of:
-
a) combining a hydroxamate-type siderophore chelating agent and a reducing agent in an aqueous solution and adjusting the pH to about 8.5; b) adding to said solution of step (a) a manganese (IV) salt; c) allowing said chelating agent to chelate the manganese of said manganese (IV) salt; and d) removing residual manganese salt from a solution resulting from step (c) above. - View Dependent Claims (15, 16, 17, 31, 32, 33, 34, 35)
-
-
19. A method of protecting cells from the toxicity of superoxide radicals comprising treating said cells with an amount of a water-soluble complex formed between a hydroxamate-type siderophore chelating agent, or analog or derivative thereof capable of complexing with manganese, and manganese sufficient to reduce or prevent superoxide radical-induced toxicity, which complex is produced by a method comprising the steps of:
-
a) combining said hydroxamate-type siderophore chelating agent, or analog or derivative thereof, and a reducing agent in an aqueous solution and adjusting the pH to about 8.5; b) adding to said solution of step (a) a manganese (IV) salt; c) allowing said chelating agent to chelate the manganese of said manganese (IV) salt; and d) removing any residual manganese salt from soltuion resulting from step (c) above. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26)
-
-
27. A method of inhibiting damage due to auto-oxidation of a substance with the subsequent formation of O2 comprising adding to said substance an amount of a water-soluble complex formed between a hydroxamate-type siderophore chelating agent, or analog or derivative thereof capable of complexing with manganese, and manganese sufficient to reduce or prevent oxidation damage, which complex is produced by a method comprising the steps of:
-
a) combining said hydroxamate-type siderophore chelating agent, or analog or derivative thereof, and a reducing agent in an aqueous solution and adjusting the pH to about 8.5; b) adding to said solution of step (a) a manganese (IV) salt; c) allowing said chelating agent to chelate the manganese of said manganese (IV) salt; and d) removing any residual mangese salt from a solution resulting from step (c) above. - View Dependent Claims (28, 29, 30)
-
- 37. A mimic of superoxide dismutase activity comprising an atom of manganese having an actual valence of 3 complexed with three hydroxamate groups.
-
38. The mimic of superoxide dismutase activity according to claiim 37 wherein said hydroxamate groups are derived from a single molecule of desferrioxamine.
- 43. A complex of a desferrioxamine and manganese.
- 46. A stable aqueous solution of a complex of a desferrioxamine and manganese, containing alkali in amount sufficient to bring the pH to about 6.
Specification